Page results
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
Easy read information for patients living with a catheter.
-
UCLH is supporting a new UK-wide health and care research registry, as part of the nation’s biggest-ever recruitment drive to clinical trials.
-
This page provides information about the use of venous sinus stents in the treatment of venous sinus stenosis and idiopathic intracranial hypertension (IIH).
-
This page provides information about endovascular treatment of Subdural Hematomas (SDH).
-
This page provides information about the sclerotherapy for low flow vascular malformations.
-
This page contains information for patients (and their family and carers) who are considering having ablation for a liver tumour.
-
This page contains information for patients (and their family and carers) who are considering having ablation for a lung tumour.
-
An ambitious project has helped make the University College Hospital Outpatients Department much more pleasant and easy to navigate.
-
A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery, according to results from a clinical trial led by researchers from UCL and UCLH.
File results
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2019/16 Antenatal unit questionnaire
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI2017328 Use of variable rate intravenous insulin infusion